Corpus Intelligence IC Memo — THOMAS H BOYD CRITICAL ACC HOSPITAL 2026-04-26 16:36 UTC
IC Memo — THOMAS H BOYD CRITICAL ACC HOSPITAL
Investment Committee Memorandum | IL | 25 beds | Grade D | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

THOMAS H BOYD CRITICAL ACC HOSPITAL

CCN 141300 | GREENE, IL | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

THOMAS H BOYD CRITICAL ACC HOSPITAL is a 25-bed community hospital in GREENE, IL with $14.3M in net patient revenue and a -8.1% operating margin. The hospital serves a payer mix of 59.8% Medicare, 0.0% Medicaid, and 40.2% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.1% to -0.7% (+737bps).

Net Revenue HCRIS$14.3M
Current EBITDA COMPUTED$-1.2M
Operating Margin COMPUTED-8.1%
Occupancy HCRIS8.4%
Revenue / Bed COMPUTED$572K
Net-to-Gross HCRIS66.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
74
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -8.1% places it below the state median. Among 74 size-comparable peers (12-50 beds), the median margin is -1.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 74 hospitals in the comp set.

HospitalStateBedsRevenueMargin
THOMAS H BOYD CRITICAL ACC HOS (Target)IL25$14.3M-8.1%
GIBSON AREA HOSPITAL AND HEALTIL25$125.0M-6.7%
GRAHAM HOSPITAL ASSOCIATIONIL43$105.0M-4.7%
PARIS COMMUNITY HOSPITALIL25$100.7M-4.2%
OSF SAINT ANTHONYS HEALTH CENTIL49$91.4M-9.8%
ST. MARGARETS HEALTH - SPRING IL44$88.1M-12.7%
SAINT JOSEPH MEMORIAL HOSPITALIL25$86.0M33.9%
MCDONOUGH DISTRICT HOSPITALIL45$79.6M-4.2%
WABASH GENERAL HOSPITALIL25$71.8M4.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$300K+210bp18mo
Cost to Collect4.5%2.5%$286K+200bp12mo
Denial Rate Reduction12.0%6.5%$283K+198bp12mo
A/R Days Reduction5200.0%3800.0%$174K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$300K
Cost to Collect
$286K
Denial Rate Reduction
$283K
A/R Days Reduction
$174K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-1.2M
+ RCM Uplift+$1.1M
Pro Forma EBITDA$-99K
Current Margin-8.1%
Pro Forma Margin-0.7%
WC Released (1x)$548K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.8M$2.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.8M$2.6M0.00x-100.0%
Bull Case9.0x11.0x$-1.6M$5.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.6M$5.6M0.00x-100.0%
Bear Case11.0x10.0x$-2.0M$-1.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.0M$-2.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 59.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 8.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 74 hospitals with 12-50 beds
  • Same-state prioritization (n=75)
  • Comp margins: P25=-7.3% / P50=-1.8% / P75=6.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.